ArticlePloS one2019

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

A V Ramanan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.